{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:57:23Z","timestamp":1791341843785,"version":"4.3.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["1H79TIO80271"],"award-info":[{"award-number":["1H79TIO80271"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["6H79TI081697"],"award-info":[{"award-number":["6H79TI081697"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006818","name":"University of Missouri-St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014883","name":"Mississippi Department of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jsat.2022.108747","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T09:42:32Z","timestamp":1645350152000},"page":"108747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Acceptance of medications for opioid use disorder in recovery housing programs in Missouri"],"prefix":"10.1016","volume":"138","author":[{"given":"Claire A.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Duello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Gochez-Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kori","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Anderson-Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel P.","family":"Winograd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2022.108747_bb0005","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2010"},{"issue":"4","key":"10.1016\/j.jsat.2022.108747_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/08897077.2019.1640833","article-title":"Underutilization of medications to treat opioid use disorder: What role does stigma play?","volume":"40","author":"Allen","year":"2019","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2022.108747_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsat.2019.06.011","article-title":"Court personnel attitudes towards medication-assisted treatment: A state-wide survey","volume":"104","author":"Andraka-Christou","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2022.108747_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: The foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"8","key":"10.1016\/j.jsat.2022.108747_bb0025","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2020.8969","article-title":"Therapies offered at residential addiction treatment programs in the United States","volume":"324","author":"Beetham","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2022.108747_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","article-title":"Discontinuation of buprenorphine maintenance therapy: Perspectives and outcomes","volume":"52","author":"Bentzley","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108747_bb0035","series-title":"Pathways to recovery and desistance: The role of the social contagion of hope","author":"Best","year":"2019"},{"key":"10.1016\/j.jsat.2022.108747_bb0040","series-title":"Recovery housing issue brief: Information for state policymakers","author":"Blue","year":"2017"},{"key":"10.1016\/j.jsat.2022.108747_bb0045","series-title":"Digital Repository","article-title":"The impact of recovery narratives on stigmatizing attitudes toward medication-assisted treatment (718)","author":"Carroll","year":"2018"},{"key":"10.1016\/j.jsat.2022.108747_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder","author":"Cioe","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108747_bb0055","author":"<collab>21st Century Cures Act"},{"key":"10.1016\/j.jsat.2022.108747_bb0060","series-title":"Medications for opioid use disorder saves lives","author":"National Academies of Sciences","year":"2019"},{"issue":"2","key":"10.1016\/j.jsat.2022.108747_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jsat.2022.108747_bb0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addbeh.2017.05.010","article-title":"Predictors of buprenorphine treatment success of opioid dependence in two Baltimore City grassroots recovery programs","volume":"73","author":"Damian","year":"2017","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2022.108747_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugpo.2019.07.006","article-title":"Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States","volume":"73","author":"David","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"12","key":"10.1016\/j.jsat.2022.108747_bb0080","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence","volume":"174","author":"Fiellen","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2022.108747_bb0085","first-page":"607","article-title":"Fair housing for sober living: How the fair housing act addresses recovery homes for drug and alcohol addiction","volume":"42","author":"Gorman","year":"2010","journal-title":"The Urban Lawyer"},{"issue":"4","key":"10.1016\/j.jsat.2022.108747_bb0090","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.0887-378X.2004.00325.x","article-title":"Diffusions of innovations in service organizations: Systematic review and recommendations","volume":"82","author":"Greenhalgh","year":"2004","journal-title":"The Milbank Quarterly"},{"key":"10.1016\/j.jsat.2022.108747_bb0095","series-title":"Change in schools: Facilitating the process","author":"Hall","year":"1987"},{"issue":"1","key":"10.1016\/j.jsat.2022.108747_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/08897077.2015.1129390","article-title":"Assessment of provider attitudes toward #naloxone on Twitter","volume":"37","author":"Haug","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2022.108747_bb0105","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10464-013-9602-6","article-title":"The role of recovery residences in promoting long-term addiction recovery","volume":"52","author":"Jason","year":"2013","journal-title":"American Journal of Community Psychology"},{"issue":"2","key":"10.1016\/j.jsat.2022.108747_bb0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1037\/a0017932","article-title":"Oxford house recovery homes: Characteristics and effectiveness","volume":"7","author":"Jason","year":"2010","journal-title":"Psychological Services"},{"issue":"8","key":"10.1016\/j.jsat.2022.108747_bb0115","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"American Journal of Public Health"},{"issue":"11","key":"10.1016\/j.jsat.2022.108747_bb0120","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamapsychiatry.2020.1511","article-title":"Methadone for opioid use disorder \u2013 Decades of effectiveness but still miles away in the US","volume":"77","author":"Joudrey","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2022.108747_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsat.2019.06.004","article-title":"Nowhere to go? Examining facility acceptance levels for serving individuals using medications for opioid used disorder","volume":"104","author":"Kepple","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2022.108747_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","article-title":"The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review","volume":"107","author":"Livingston","year":"2012","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.jsat.2022.108747_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: The current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2022.108747_bb0140","series-title":"The co-use of methamphetamine and opioids among patients in treatment in Oregon, USA","author":"Lopez","year":"2019"},{"key":"10.1016\/j.jsat.2022.108747_bb0145","unstructured":"Luce, R. (n.d.). The social model of recovery handout. The John W. Clem Recovery House. https:\/\/mha.ohio.gov\/Portals\/0\/assets\/SchoolsAndCommunities\/CommunityAndHousing\/HousingResources\/The-Social-Model-of-Recovery-Handout.pdf."},{"issue":"12","key":"10.1016\/j.jsat.2022.108747_bb0150","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis","volume":"24","author":"Ma","year":"2018","journal-title":"Molecular Psychiatry"},{"issue":"5","key":"10.1016\/j.jsat.2022.108747_bb0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10597-017-0218-4","article-title":"Oxford house residents' attitudes toward medication assisted treatment use in fellow residents","volume":"54","author":"Majer","year":"2018","journal-title":"Community Mental Health Journal"},{"issue":"1","key":"10.1016\/j.jsat.2022.108747_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000331007","article-title":"Effectiveness of therapeutic communities: A systematic review","volume":"18","author":"Malivert","year":"2012","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2022.108747_bb0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jsat.2018.12.004","article-title":"Sober living house characteristics: A multilevel analyses of factors associated with improved outcomes","volume":"98","author":"Mericle","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2022.108747_bb0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/02791072.2014.976726","article-title":"A critical component of the continuum of care for substance use disorders: Recovery homes in Philadelphia","volume":"47","author":"Mericle","year":"2015","journal-title":"Journal of Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.jsat.2022.108747_bb0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/02791072.2017.1342154","article-title":"Recovery housing: Evolving models to address resident needs","volume":"49","author":"Mericle","year":"2017","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2022.108747_bb0185","article-title":"Assessing technical assistance needs among recovery residence operators in the United States","author":"Miles","year":"2020","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.jsat.2022.108747_bb0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/00952990.2020.1719410","article-title":"Supporting individuals using medications for opioid use disorder in recovery residences: Challenges and opportunities for addressing the opioid epidemic","volume":"46","author":"Miles","year":"2020","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2022.108747_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","article-title":"Medication treatment for opioid use disorders in substance use treatment facilities","volume":"38","author":"Mojtabai","year":"2019","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2022.108747_bb0200","series-title":"Narcotics anonymous and persons receiving medication-assisted treatment","year":"2016"},{"issue":"1","key":"10.1016\/j.jsat.2022.108747_bb0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08897077.2019.1695038","article-title":"Persisting gaps in M-OUD coverage at post-discharge recovery houses necessitate our continued advocacy","volume":"41","author":"Patel","year":"2020","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2022.108747_bb0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/02791072.2008.10400625","article-title":"A clean and sober place to live: Philosophy, structure, and purported therapeutic factors in sober living houses","volume":"40","author":"Polcin","year":"2008","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.jsat.2022.108747_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0022042615616432","article-title":"Challenges and rewards of conducting research on recovery residences for alcohol and drug disorders","volume":"46","author":"Polcin","year":"2016","journal-title":"Journal of Drug Issues"},{"issue":"5","key":"10.1016\/j.jsat.2022.108747_bb0235","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/02791072.2014.960112","article-title":"Maximizing social model principles in residential recovery settings","volume":"46","author":"Polcin","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.jsat.2022.108747_bb0240","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ADM.0000000000000584","article-title":"Comparing reasons for starting and stopping methadone, buprenorphine, naltrexone treatment among a sample of white individuals with opioid use disorder","volume":"14","author":"Randall-Kosich","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2022.108747_bb0245","series-title":"Community pharmacists and substance use disorders: Attitudes, knowledge and practices","author":"Rao","year":"2018"},{"issue":"2","key":"10.1016\/j.jsat.2022.108747_bb0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsat.2006.09.002","article-title":"Client and counselor attitudes toward the use of medications for treatment of opioid dependence","volume":"32","author":"Rieckmann","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108747_bb0255","series-title":"Diffusion of innovations","author":"Rogers","year":"1995"},{"issue":"5","key":"10.1016\/j.jsat.2022.108747_bb0260","article-title":"Impact of long-term buprenorphine treatment on adverse health care outcomes in Medicaid","volume":"39","author":"Samples","year":"2020","journal-title":"Heath Affairs"},{"key":"10.1016\/j.jsat.2022.108747_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e509","article-title":"Multiple significance tests: The Bonferroni correction","volume":"344","author":"Sedgwick","year":"2012","journal-title":"BJM"},{"key":"10.1016\/j.jsat.2022.108747_bb0270","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2022.108747_bb0275","series-title":"The recovery housing system in Missouri: Community-based system dynamics group model building workshop report","author":"Stringfellow","year":"2019"},{"key":"10.1016\/j.jsat.2022.108747_bb0290","series-title":"The wrong way to treat opioid addiction","author":"Szalawitz","year":"2018"},{"key":"10.1016\/j.jsat.2022.108747_bb0295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients' beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108747_bb0300","series-title":"Mental Health Services Administration. 2017 National Survey on Drug Use and Health: Detailed Tables","year":"2019"},{"issue":"1","key":"10.1016\/j.jsat.2022.108747_bb0305","first-page":"23","article-title":"Suboxone: Rationale, science, misconceptions","volume":"18","author":"Velander","year":"2018","journal-title":"Ochsner Journal"},{"issue":"9","key":"10.1016\/j.jsat.2022.108747_bb0310","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/journalofethics.2017.19.9.stas1-1709","article-title":"Why it's inappropriate not to treat incarcerated patients with opioid agonist therapy","volume":"19","author":"Wakeman","year":"2017","journal-title":"AMA Journal of Ethics"},{"issue":"2","key":"10.1016\/j.jsat.2022.108747_bb0315","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.jsat.2022.108747_bb0320","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10826084.2017.1363238","article-title":"Barriers to medications for addiction treatment: How stigma kills","volume":"53","author":"Wakeman","year":"2018","journal-title":"Substance Use & Misuse"},{"issue":"2","key":"10.1016\/j.jsat.2022.108747_bb0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder","volume":"177","author":"Williams","year":"2020","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jsat.2022.108747_bb0330","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/00952990.2019.1605372","article-title":"The case for a medication first approach to the treatment of opioid use disorder","volume":"45","author":"Winograd","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222000290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222000290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:57:16Z","timestamp":1760039836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547222000290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":60,"alternative-id":["S0740547222000290"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108747","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptance of medications for opioid use disorder in recovery housing programs in Missouri","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108747"}}